Prognostic factors for abatacept retention in patients who received at least one prior biologic agent: an interim analysis from the observational, prospective ACTION study

H.G. Nusslein, R. Alten, M. Galeazzi, H.M. Lorenz, M.T. Nurmohamed, W.G. Bensen, G.R. Burmester, H.H. Peter, K. Pavelka, M. Chartier, C. Poncet, C. Rauch, M. Le Bars

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Article number176
JournalBMC Musculoskeletal Disorders
Volume16
DOIs
Publication statusPublished - 2015

Cite this